Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Respiri Limited ( (AU:RSH) ) has issued an announcement.
Respiri Limited has announced a webinar scheduled for March 17, 2025, where Managing Director Marjan Mikel will discuss the company’s U.S. growth plans, major deals, and the future of connected care. This event signifies Respiri’s commitment to expanding its presence in the U.S. market, leveraging its advanced healthcare solutions to enhance patient care and reduce healthcare costs. The announcement underscores the company’s strategic focus on integrating their technologies into existing healthcare systems, thereby positioning themselves as a key player in the chronic disease management sector.
More about Respiri Limited
Respiri Limited is a Connected Care Management Company that specializes in remote patient monitoring services, particularly in the USA. The company is a leader in medical devices and MedTech, focusing on chronic disease management through innovative technologies and strategic partnerships. Their flagship product, wheezo®, is an FDA-approved device for detecting wheeze, integrated into remote patient monitoring programs.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $44.91M
See more insights into RSH stock on TipRanks’ Stock Analysis page.